Advancing potential breakthrough medicines for rare endocrine diseases of substantial medical need with validated molecular targets.
- Year invested 2020
- Investment Stage Early
- Board Members
- Sectors
- Investment Status Current
- Website mbxbio.com/
- Company Status Private